Clinical Trial Update: Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing neoadjuvant endocrine therapy versus chemotherapy in premenopausal patients with ER-positive, HER2-negative breast cancer is in recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Peking University | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING